CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McINTYRE, J.W. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by McINTYRE, J.W. R.

Canadian Journal of Anesthesia, Vol 7, 176-178, Copyright © 1960 by Canadian Anesthesiologists' Society

Ataractics and the Recovery Room, with Reference to Triflupromazine, I

J.W. R. McINTYRE F.F.A.R.C.S., D.A.

Prophylactic treatment of emergence vomiting and restlessness is considered to be indicated. when these complications will endanger the patient's life or the operative site. This is particularly the case in plastic and ophthalmic surgery and in patients suffering from coronary arterial insufficiency. The cautious, intravenous administration of triflupromazine in dosage 0.1–1.0 mg./lO lb. body weight prior to the termination of anaesthesia reduced the incidence of these complications. Significant depression of the blood pressure was unusual and when it did occur was unrelated to the dosage used.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1960 by the Canadian Anesthesiologists' Society.